Accepted for/Published in: JMIR Medical Informatics
Date Submitted: Feb 21, 2026
Date Accepted: Jul 21, 2026
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Artificial Intelligence in Tuberculosis: Global Research Trends and Bibliometric Insights (2000–2025)
ABSTRACT
Background:
Tuberculosis (TB) remains a major global health challenge despite prevention efforts. Artificial intelligence (AI) shows promise for TB management through imaging analysis and decision support, but systematic evaluation of research trends and implementation challenges is needed.
Objective:
To analyze development patterns, collaboration networks, and knowledge structure of AI applications in TB management through bibliometric analysis of Web of Science publications, identifying research frontiers and translational gaps.
Methods:
This study conducted bibliometric analysis of Web of Science publications (2000-2025) using VOSviewer, CiteSpace, and Bibliometrix R, examining publication trends, collaboration networks, and knowledge domains through scientific knowledge mapping.
Results:
Analysis shows substantial growth in AI applications for TB management during 2000-2025, with post-2018 publication growth of 29. 7% and citation growth of 54. 2% annually. Research concentrates on imaging analysis (53. 3% of highly-cited papers), drug resistance prediction (20%), and drug discovery (26. 7%). The US leads with 346 publications, 12,143 citations, and collaboration strength of 409, while China ranks second with 304 publications but lower collaboration (141) and citations (4,251). High-income nations focus on technology development; high-burden countries emphasize clinical translation. Technological journals focus on algorithm optimization, while clinical journals prioritize validation. "Machine learning" dominates the keyword landscape (1,459 occurrences), while clinical terminology such as "intensive care unit" (243) appears frequently but at substantially lower frequencies. Of highly-cited studies, 60% focus on technical validation and only 26. 7% address clinical applications. Main research gaps include insufficient cross-regional data sharing, limitations in atypical TB image recognition, and poor integration of socioeconomic variables.
Conclusions:
AI-tuberculosis research shows rapid development focused on technical innovation, but clinical translation remains limited. Future advances require strengthening interdisciplinary collaboration and implementation science to transition from technology-driven to needs-based approaches, particularly addressing deployment challenges in high-burden settings.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.